Finding Health Online
News for:   
 

   
 

For this drug, our server compiled this detailed Chemical Profile.

You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.

 

 
 
 
 

 

Click the Chemical Profile link above for detailed information.

Visit Betterchem's Drug Index for…

  • Exclusivity
    Patents and market exclusivity
  • Drug Information
    Prescribing and other information
  • DMFs
    Type 2 drug master files
  • Databases
    Free access to database search
  • 21 CFR
    FDA regulations for this drug
  • Federal Register
    FR search results for this drug
  • Drug Recalls
    For Rx's using this API

  FDA Approval Activities for this Drug…

Lovenox (enoxaparin sodium) Injection, Aventis NDA 20-164/S51 6/20/03 7/6/03 Lovenox (enoxaparin sodium) Injection, Aventis NDA 20-164/S50 7/1/03 7/8/03 Lovenox (enoxaparin sodium) Injection, 300 mg/3.0, Aventis Products NDA 20-164/S43 1/23/03 1/27/03 Lovenox (enoxaparin sodium) Injection, Aventis Products NDA 20-164/S40, S45 & S6 1/9/02 2/8/02 Lovenox (enoxaparin sodium) Injection Aventis Products NDA 20-164/S036 11/17/00 11/27/00 11/27/00 Lovenox (enoxaparin sodium) Injection Aventis Products NDA 20-164/S034 9/27/00 9/29/00 Lovenox (enoxaparin sodium) Injection Aventis Products NDA 20-164/S020 8/4/00 8/4/00 Lovenox (enoxaparin sodium) Injection Rhone-Poulenc Rorer NDA 20-164/S010 1/30/98 4/24/03 Lovenox (enoxaparin sodium) Injection Rhone-Poulenc Rorer NDA 20-164/S015 12/31/98 7/3/00 Lovenox (enoxaparin sodium) Injection, Subcutaneous (SC), or OTC: Rhone-Poulenc Rorer NDA 20-164 12/31/98 1/5/99 1/5/99 Lovenox Indications:(1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2) the outpatients treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium. Lovenox (enoxaparin sodium) Injection, Aventis Pharmaceuticals Lovenox (enoxaparin sodium) Injection, Aventis Pharmaceuticals Lovenox (enoxaparin sodium) Injection, Aventis Pharmaceuticals Lovenox (enoxaparin sodium, injection), Aventis Pharmaceuticals, Control Supplement | Lovenox (enoxaparin sodium) injection, Aventis Pharma, Labeling Revision

Visit Betterchem's Drug Index for FDA's latest approval information.


 

Find other drugs…

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News

© 2011 FindingHealthOnline™